Guardant Health Inc. Common Stock is a precision oncology company that develops and commercializes liquid biopsy tests, which are used to detect and monitor cancer. The company aims to improve cancer care by leveraging its proprietary technology for comprehensive genomic profiling of cell-free circulating tumor DNA.
